Arrowstreet Capital Limited Partnership Has $762.10 Million Holdings in CME Group Inc. $CME

Arrowstreet Capital Limited Partnership decreased its stake in CME Group Inc. (NASDAQ:CME) by 16.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,580,320 shares of the financial services provider’s stock after selling 494,453 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in CME Group were worth $762,098,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. FLC Capital Advisors purchased a new stake in CME Group during the 4th quarter worth approximately $2,122,000. First Bank & Trust purchased a new position in shares of CME Group during the 4th quarter valued at approximately $1,325,000. Mn Services Vermogensbeheer B.V. boosted its stake in shares of CME Group by 2.9% during the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 140,210 shares of the financial services provider’s stock valued at $38,289,000 after buying an additional 3,931 shares during the last quarter. MOKAN Wealth Management Inc. grew its position in shares of CME Group by 138.8% during the fourth quarter. MOKAN Wealth Management Inc. now owns 7,144 shares of the financial services provider’s stock worth $1,953,000 after buying an additional 4,152 shares in the last quarter. Finally, HighTower Advisors LLC increased its stake in shares of CME Group by 6.9% in the fourth quarter. HighTower Advisors LLC now owns 352,922 shares of the financial services provider’s stock worth $96,376,000 after buying an additional 22,692 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group beat Q2 estimates, reporting $2.99 EPS versus $2.91 expected and revenue of about $1.71 billion versus $1.68 billion expected, supporting the stock. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which likely boosted investor confidence. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Record market data revenue and strong trading volumes suggested core business momentum remains healthy, another bullish catalyst for the stock. CME Group jumps after Q2 earnings beat and strong trading activity
• Neutral Sentiment: UBS reiterated a Hold rating with a $260 target, signaling solid fundamentals but limited upside from current levels. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
• Negative Sentiment: JPMorgan kept an Underweight rating and BofA maintained an Underperform stance, both implying analysts still see downside risk despite the earnings beat. Benzinga report on JPMorgan price target change Benzinga report on Bank of America price target change

CME Group Stock Up 2.0%

CME stock opened at $254.32 on Friday. The firm has a market cap of $92.16 billion, a price-to-earnings ratio of 21.57, a PEG ratio of 3.10 and a beta of 0.25. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16. The firm has a fifty day moving average price of $255.00 and a two-hundred day moving average price of $281.41. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business posted $2.96 EPS. The company’s quarterly revenue was up .8% on a year-over-year basis. Research analysts predict that CME Group Inc. will post 12.17 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CME shares. Jefferies Financial Group cut their price target on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. UBS Group dropped their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research report on Monday, July 6th. Morgan Stanley upped their target price on shares of CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Finally, Bank of America boosted their price objective on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday. Eleven research analysts have rated the stock with a Buy rating, four have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $291.81.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard acquired 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the sale, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.